Medtronic plc (MDT) Earnings Call Transcripts

Medtronic plc's Latest Earnings Call - September 15, 2026

In the first quarter of fiscal year 2027, Medtronic plc (MDT:US) reported a revenue of $7.2 billion, reflecting a 7% increase year-over-year, which was inline with expectations. Earnings per share (EPS) came in at $1.05, beating estimates by $0.05. Management raised their full-year revenue guidance to a midpoint of 7.5%, indicating confidence in sustained growth driven by innovation and strong procedure volumes across key franchises.

Reported metrics

Guidance from management

Management raised full-year revenue guidance to a midpoint of 7.5%, citing strong performance in core cardiovascular and surgical businesses, with expectations for continued strength in the second half of the year.

What management said

I think we had announced that we would do it within a relatively on time frame after the first page. And yes, look, it's -- it's performing well. Q4 numbers for them were great. Q1 numbers were even better. The innovation cycle, every product launch is happening earlier than they expect. So they're on a role from an innovation perspective. So the business is doing great and it's the right time to do it. And again, th...

So first, I don't want to spoil the suspense so we've got a big Investor Day coming in December on the 10th and 11th, and that will be a key topic, right, because that's the #1 question we get from everyone is have you made that growth sustainable? But without spoiling everything, it's back to this concept of the base has become stronger CRM, CST surgical to innovation. And then we've got these 4 generational growth ...

What analysts pressed on

Analysts expressed concerns about the sustainability of growth rates, particularly in the neuroscience segment, which grew only 3% in Q1. There were also questions regarding the impact of recent acquisitions on earnings dilution and how Medtronic plans to manage that moving forward.

Main topics on the call

• Revenue Growth Acceleration — Medtronic's revenue grew 7% year-over-year, driven by strong performance in cardiac rhythm management and surgical segments. Management stated, "Our biggest franchises, cardiac rhythm management, surgical, spine, have al...
• AI Integration in Products — Management highlighted the role of AI in enhancing procedure outcomes and operational efficiency, stating, "AI just gives us an opportunity to improve the procedure workflow, make the results better for the physicians." ...
• Strong Cash Flow Performance — The company reported robust free cash flow performance, with management noting, "Q1 was very strong" in cash collections, which supports ongoing investments and operational stability.
• Sustained Growth Drivers — Management identified four key growth drivers, including cardiac ablation and robotic surgery, with cardiac ablation surpassing $2 billion in revenue. They stated, "These 4 generational growth drivers are kind of in rapi...

Read the full Medtronic plc transcript (September 15, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 92 Medtronic plc earnings call transcripts on record, spanning January 13, 2020 to September 15, 2026. Based on this history, Medtronic plc reports quarterly. The most recent call on file is dated September 15, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MDT

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

92

First call

January 13, 2020

Most recent

September 15, 2026

Reporting cadence

quarterly